Lilly reports major loss due legal settlement

... Investor's Business Daily: Breaking News a.Link{ color: #03f; text-decoration:underline; } Register Now Subscribe/Renew Take a FREE Trial!

RESEARCH TOOLS The IBD Difference Today in IBD Daily Stock Analysis Investing Tools eIBDTM - Digital Edition IBDTM eTables IBDTM 100 SmartLink Daily Graphs OnlineŽ IBDTMextra!

Newsletter LEARNING TOOLS IBD Workshops IBD Webcasts IBD Community Investor's Corner IBD Learning Center CAN SLIMTM Ask IBDTM SERVICES IBD Store Rates & Calculators IBD Retail Locations Contact IBD Corporate News About IBD/Press Info ADVERTISING IBD Partners Classified Reprints Media Kit Online Exclusives: Make investors.com your homepage Register Now on investors.com and receive exclusive benefits Lilly reports major loss due legal settlement By Val Brickates Kennedy Last Updated: 7/21/2005 3:08:57 PM BOSTON (MarketWatch) - Drugmaker Eli Lilly reported a major second-quarter loss early Thursday, due largely to a $1.1 billion pre-tax charge for the settlement of product liability litigation over its blockbuster drug Zyprexa.Shares of Lilly were down 1.5% at $56.41 on Thursday.For the quarter ended June 30, Lilly (LLY) lost $252 million, or 23 cents a ...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news